Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: Effects of glucagon-like peptide 2

Nutrition and Cancer

Volumn 37, Issue 2, 2000, Pages 215-222

  Chance, William T ^a,b   Sheriff, Sulaiman ^c   Foley Nelson, Teri ^c   Thomas, Ingrid ^c   Balasubramaniam, A ^c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BACTERIAL TRANSLOCATION; CELL PROLIFERATION; COLON; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE DEFICIENCY; MALE; NONHUMAN; RAT; SMALL INTESTINE; TOTAL PARENTERAL NUTRITION;

ANIMALS; BACTERIAL TRANSLOCATION; DNA; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICROVILLI; NEOPLASMS; PARENTERAL NUTRITION; PEPTIDES; RATS; RATS, INBRED F344;

EID: 0033639262     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC372_15     Document Type: Article

References (50)

1. The immediate causes of death in cancer
2. Prognostic effect of weight loss prior to chemotherapy in cancer patients
3. Survival with inoperable lung cancer: An integration of prognostic variables based on simple clinical criteria
4. Cachexia, the metabolic component of neoplastic diseases
5. A prospective, randomized study of adjuvant parenteral nutrition in the treatment of sarcomas: Results of metabolic and survival studies
6. Parenteral nutrition: Is it oncologically logical?
7. Small intestinal mass of the rat is partially determined by indirect effects of intraluminal nutrition
8. Speed of onset of adaptive mucosal hypoplasia and hypofunction in the intestine of parenterally fed rats
9. Total parenteral nutrition and cancer clinical trials
10. Parenteral nutrition associated with increased infection rate in children with cancer
11. Total parenteral nutrition: Iatrogenic immunosuppression
12. The effect of parenteral nutrition on gastrointestinal immunity
13. Total parenteral nutrition promotes bacterial translocation from the gut
14. Effect of an elemental diet on body composition: A comparison with intravenous nutrition
15. Induction of intestinal epithelial proliferation by glucagon-like peptide 2
16. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2
17. Acivicin reduces tumor growth during total parenteral nutrition (TPN)
18. Determination of protein: A modification of the Lowry method that gives a linear photometric response
19. Observation on the chemical determination of deoxyribonucleic acid in animal tissues
20. The immunosuppressive effects of the in vivo administration of endotoxin as influenced by macrophages
21. The efficacy of nutritional assessment and support in cancer surgery
22. Glutamine and the preservation of gut integrity
23. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans
24. Perioperative total parenteral nutrition in surgical patients
25. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice
26. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide-2
27. 2 prevents gut atrophy during intravenous feeding but not bacterial translocation
28. Combined effects of glutamine and epidermal growth factor on the rat intestine
29. The proliferative effects of urogastrone-epidermal growth factor (EGF) on the intestinal epithelium
30. Preservation of intestine protein by peptide YY during total parenteral nutrition
31. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog
32. Neurotensin stimulates growth of small intestine in rats
33. Effects of nucleosides and a nucleotide mixture on gut mucosal barrier function on parenteral nutrition in rats
34. Effects of growth hormone and insulin-like growth factor-I (IGF-I) treatments on the nitrogen metabolism and hepatic IGF-I-messenger RNA expression in postoperative parenterally fed rats
35. GH and IGF-I differentially increase protein synthesis in skeletal muscle and jejunum of parenterally fed rats
36. Beneficial effects of insulin-like growth factor-I on epithelial structure and function in parenterally fed rat jejunum
37. The insulin-like growth factor Lance 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression
38. Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin, and vasoactive intestinal peptide receptors in gastrointestinal adenocarcinoma samples: Where are they really located?
39. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer growth in cell culture and in cells xenografted into nude mice
40. Glucagonlike peptide-2 enhances small intestine absorptive function and mucosal mass in vivo
41. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2
42. An enteroglucagon tumour in man
43. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
44. Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia
45. Ileal glucagon gene expression: Ontogeny and response to massive small bowel resection
46. GLP-2 augments the adaptive response to massive intestinal resection in rat
47. Intestine growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats
48. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
49. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery?
50. Total parenteral nutrition-induced changes in gut mucosal function: Atrophy alone is not the issue